Abstract
Background: The influenza virus is one of the most critical threats to public health with major economic impact. Though annual influenza vaccination is currently the most effective prevention strategy against flu epidemics and pandemics, the mutational evolution of the influenza virus tends to reduce the effectiveness of strain-specific vaccines. Methods: For past decades, a broad spectrum of potentially universal influenza vaccines has been thoroughly investigated to suppress different strains and subtypes of influenza virus concomitantly. Universal influenza vaccines were attempted to be designed to target conserved regions of surface receptors to provide the necessary preventive strategy against new influenza outbreaks. Conclusion: Notably, the influenza hemagglutinin (HA) receptor has evolutionary conserved domains that can serve as basis for the rational design of a universal influenza vaccine. In this review, we examine recent studies on HA-based universal influenza vaccines and address their molecular mechanism.
Keywords: Influenza virus, universal influenza vaccine, hemagglutinin (HA), antiviral immunity.
Current Pharmaceutical Design
Title:A Perspective on Rational Designs of a Hemagglutinin Based Universal Influenza Vaccine
Volume: 22 Issue: 23
Author(s): Thanh D. Van, Nhut Tran, Ly Le and Frank Eisenhaber
Affiliation:
Keywords: Influenza virus, universal influenza vaccine, hemagglutinin (HA), antiviral immunity.
Abstract: Background: The influenza virus is one of the most critical threats to public health with major economic impact. Though annual influenza vaccination is currently the most effective prevention strategy against flu epidemics and pandemics, the mutational evolution of the influenza virus tends to reduce the effectiveness of strain-specific vaccines. Methods: For past decades, a broad spectrum of potentially universal influenza vaccines has been thoroughly investigated to suppress different strains and subtypes of influenza virus concomitantly. Universal influenza vaccines were attempted to be designed to target conserved regions of surface receptors to provide the necessary preventive strategy against new influenza outbreaks. Conclusion: Notably, the influenza hemagglutinin (HA) receptor has evolutionary conserved domains that can serve as basis for the rational design of a universal influenza vaccine. In this review, we examine recent studies on HA-based universal influenza vaccines and address their molecular mechanism.
Export Options
About this article
Cite this article as:
D. Van Thanh, Tran Nhut, Le Ly and Eisenhaber Frank, A Perspective on Rational Designs of a Hemagglutinin Based Universal Influenza Vaccine, Current Pharmaceutical Design 2016; 22 (23) . https://dx.doi.org/10.2174/1381612822666160419144352
DOI https://dx.doi.org/10.2174/1381612822666160419144352 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Curcumin Conjugates and Metallocomplexes as Lead Compounds for Development of Anticancer Agents - A Short Review
Current Bioactive Compounds Pharmacologic Ovarian Preservation in Young Women Undergoing Chemotherapy
Current Medicinal Chemistry Anti-Allergic Action of Glucocorticoids: Comparison with Immunosuppressive and Anti-Inflammatory Effects
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors
Mini-Reviews in Medicinal Chemistry Diabetic Retinopathy and Atherosclerosis: is there a Link?
Current Diabetes Reviews Stem Cell Therapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Towards Retinoid Therapy for Alzheimers Disease
Current Alzheimer Research Growth Inhibition of Human Non-Small Lung Cancer Cells H460 By Green Tea and Ginger Polyphenols
Anti-Cancer Agents in Medicinal Chemistry Quercetin in Attenuation of Ischemic/Reperfusion Injury: A Review
Current Molecular Pharmacology Cancer Genetics and Drug Discovery in Mice
Letters in Drug Design & Discovery Studies on the Biotransformations and Biodistributions of Metal-Containing Drugs Using X-Ray Absorption Spectroscopy
Current Topics in Medicinal Chemistry Celecoxib Inhibits Helicobacter pylori-induced Invasion of Gastric Cancer Cells Through an Adenine Nucleotide Translocator-Dependent Mechanism
Anti-Cancer Agents in Medicinal Chemistry The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine
Current Molecular Medicine Chemoprevention of Colorectal Cancer: Ready for Routine Use?
Current Topics in Medicinal Chemistry Experimental Methods and Transport Models for Drug Delivery Across the Blood-Brain Barrier
Current Pharmaceutical Biotechnology A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor
Current Cancer Drug Targets Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept
Current Rheumatology Reviews Minocycline as Add-On Treatment Decreases the Negative Symptoms of Schizophrenia; A Randomized Placebo-Controlled Clinical Trial
Recent Patents on Inflammation & Allergy Drug Discovery Protein Tyrosine Phosphatases, New Targets for Cancer Therapy
Current Cancer Drug Targets Statins and Cancer
Anti-Cancer Agents in Medicinal Chemistry